Feds build biodata hub, but industry gets the keys
H.R. 9307 — Web of Biological Data Act of 2026 · Filed by Matt Van Epps (R-TN) · 2 cosponsors · Introduced Jun 11, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill establishes a centralized federal database called the Web of Biological Data, managed by the Department of Energy through a National Laboratory, to aggregate biological research data funded by the government and make it accessible to researchers via a single online portal. The system will use artificial intelligence and advanced computational tools to organize and analyze the data, with phased rollout over 5 years and $420 million in initial funding, while maintaining cybersecurity protections and restricting access from certain countries.
Why we flagged it
The bill's core function is establishing a federally funded, centralized biological data repository to serve researchers and advance scientific discovery. While it involves industry partnerships and AI integration, the primary mechanism is a public-sector research infrastructure project, not a corporate subsidy or deregulation.
What the text implies
- Industry members gain structured access to federally funded biological datasets through the advisory board (4 of 11 seats) and cost-sharing partnerships, potentially creating competitive advantage for private biotech firms without explicit data-licensing restrictions.
- The bill restricts data sharing with certain countries 'as determined by Secretary' — a broad discretionary power that could be weaponized for geopolitical purposes or create barriers to international scientific collaboration.
The full analysis lists 5 implications of this text.
Who stands to gain
biotechnology companies; pharmaceutical firms; AI/machine learning vendors